Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
- Facilitation Desk
- Complaints

Home > News & Updates > Regulatory Updates > Clinical Trials > GCP_Inspectorate_Notifications

GCP_Inspectorate_Notifications

Ijaz Mustafa Clinical Trials, Notifications May 3, 2023May 3, 2023

GCP_Inspectorate_Notification-I Download

GCP_Inspectorate_Notification-II Download

Share this:

Twitter
Facebook

← Recall Alert: Drug Product; Spadix Injection (Batch# 570) by M/s. Tabros Pharma Karachi
Recall Alert: Drug Product; Fluorazine 1mg Tablet (Batch # T-2065) CKD Pharmaceuticals Pak (Pvt) Ltd, Karachi →

DRAP at a Glance
Organization
Legislation
- Acts
- Rules
- Regulations
- SROs
- Notifications
Boards and Committees
Quality Management System
- Quality Policy
- Management Reviews
Contact Us

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem